Efficacy of the novel thromboxane receptor antagonist NTP42 alone, or in combination with Sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension
2 September 2019 (08:30 - 12:30)
Organised by:
Abstract
About the speaker
ATXA Therapeutics Limited, Dublin (Ireland)
10 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
08:30 CET
